SCHEMBL21992768

SCHEMBL21992768

O=c1nc2n(c3ccccc13)CC/C2=C\c1ccc2c(c1)OCO2

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SMARCA4 P51532 6/20 0.57
▸ PBRM1 Q86U86 3/20 0.57
▸ DYRK1A Q13627 2/20 0.49
▸ DYRK2 Q92630 2/20 0.49
▸ DYRK1B Q9Y463 2/20 0.49
▸ MAPT P10636 6/20 0.47
▸ ALDH1A1 P00352 8/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ LMNA P02545 3/20 0.47
▸ TDP1 Q9NUW8 2/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ KDM4E B2RXH2 4/20 0.46
▸ NPC1 O15118 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ HPGD P15428 2/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ USP2 O75604 1/20 0.41
▸ ADAM17 P78536 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21931881 0.84 RAB9A (0.64) DYRK1ADYRK2DYRK1BMAPTALDH1A1
SCHEMBL21993751 0.81 SMARCA4 (0.60) SMARCA4PBRM1KMT2AMEN1KDM4E
SCHEMBL21931879 0.81 SMARCA4 (0.60) SMARCA4PBRM1MAPTALDH1A1KMT2A
SCHEMBL21931884 0.81 SMARCA4 (0.60) SMARCA4PBRM1MAPTALDH1A1KMT2A
SCHEMBL21993276 0.80 SMARCA4 (0.64) SMARCA4PBRM1MAPTALDH1A1KMT2A
SCHEMBL21992956 0.79 MEN1 (0.61) SMARCA4PBRM1MAPTALDH1A1KMT2A
SCHEMBL21992767 0.77 CCR3 (0.63) SMARCA4PBRM1DYRK1ADYRK1BMAPT
SCHEMBL21993284 0.77 SMARCA4 (0.61) SMARCA4PBRM1KMT2AMEN1KDM4E
SCHEMBL21993759 0.77 SMARCA4 (0.61) SMARCA4PBRM1KMT2AMEN1KDM4E
SCHEMBL21992771 0.77 PBRM1 (0.64) SMARCA4PBRM1KDM4ENPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11583530-B2 Compounds for the prevention and treatment of medical disorders and uses thereof GALECTIN SCIENCES, LLC (US) 2023-02-21 — — US disclosed
US-20200147088-A1 Compounds for the Prevention and Treatment of Medical Disorders and Uses Thereof GALECTIN SCIENCES, LLC 2020-05-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200147088-A1 Compounds for the Prevention and Treatment of Medical Disorders and Uses Thereof LGALS1, LGALS2, LGALS3 SMARCA4 4569/4885PBRM1 4399/4885DYRK1A 4276/4885
US-11583530-B2 Compounds for the prevention and treatment of medical disorders and uses thereof LGALS1, LGALS2, LGALS3 SMARCA4 4569/4885PBRM1 4399/4885DYRK1A 4276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback